Clinical Pharmacy and Patient Safety
What the domain tests
This domain tests patient-centered medication optimization and error prevention: medication reconciliation, adverse drug event recognition, high-alert medications, renal dosing, deprescribing, and safety reporting. Questions often describe a deterioration after a medication change and ask for the most likely cause and safest action.
Core rules and concepts
- Medication reconciliation compares the pre-admission list with current orders at transitions of care; unexplained discrepancies are a major error source.
- High-alert medicines include anticoagulants, insulin, opioids, concentrated electrolytes, chemotherapy, and neuromuscular blockers. They require independent checks, clear labeling, and standardized protocols.
- Adverse drug events may be dose-related, idiosyncratic, or interaction-related. Consider timing, known effects, and objective data such as renal function, INR, glucose, or ECG.
- Deprescribing is appropriate when harms exceed benefits, especially in older adults with falls, cognitive impairment, or limited life expectancy. Do not stop drugs abruptly if withdrawal or rebound is likely.
- Report suspected errors and serious adverse reactions through the required institutional and national channels.
Worked example
An older adult on an ACE inhibitor, a diuretic, and a newly added NSAID develops rising creatinine and hyperkalemia. The combination can cause a “triple whammy” acute kidney injury: the NSAID reduces renal prostaglandins, the ACE inhibitor reduces efferent arteriolar tone, and the diuretic reduces volume. The correct reasoning is to stop the NSAID, assess volume and renal function, review potassium-raising drugs, and avoid simply blaming age. The trap is missing the temporal link to the new NSAID.
Traps that cost marks
Do not attribute new confusion or falls automatically to aging. Do not adjust renal doses by serum creatinine alone without estimating clearance. Do not continue a contraindicated drug because it was started by a specialist. Do not ignore withdrawal risks when deprescribing.
Key points
- Reconciliation at transitions prevents medication errors.
- High-alert drugs need independent checks and protocols.
- The “triple whammy” is NSAID + ACEi/ARB + diuretic.
- Deprescribe when harms outweigh benefits, with a taper plan if needed.
- Report serious adverse events and errors.